LATEST
Tue, Sep 1, 2026
Loading weather...
politics

Cipla inks exclusive licensing agreement with SBP Group for ADC Rolditamig Deuderuxtecan

Cipla said that it has entered into an exclusive license and supply agreement with Chia Tai Tianqing Pharmaceutical Group Co. for Rolditamig Deuderuxtecan, a potential best-in-class HER2 bispecific antibody-drug conjugate (ADC).

Original reporting: Business Standard PoliticsRead original report →
Have feedback on this article?Report error or suggestion

Read More from politics

Boat Capsizes in Srikakulam; Fisherman Dies, 3 Rescued

Of the four fishermen aboard, three managed to escape safely, while one fisherma...

Read Article »

Sonam Wangchuk explains why he softened Dharmendra Pradhan resignation demand

“By 22 I didn't see resignation as the first priority,” Sonam Wangchuk said, add...

Read Article »

Nepal Floods: Rescue Underway for Workers Trapped in Rasuwa Tunnel

Nepal Police Deputy Inspector General D Regmi said the tunnel houses several bui...

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.